Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Journal of Diabetes and Its Complications|August 27, 2010
Selective modulation of PPARγ activity can lower plasma glucose without typical thiazolidinedione side-effects in patients with Type 2 diabetesFredrick L Dunn, Linda S Higgins, Jill Fredrickson, et al.Journal of Digital Imaging|June 8, 2023
Deep Ensembles Are Robust to Occasional Catastrophic Failures of Individual DNNs for Organs Segmentations in CT ImagesYury Petrov, Bilal Malik, Jill Fredrickson, et al.Journal of Digital Imaging|May 8, 2020
Tumor Segmentation and Feature Extraction from Whole-Body FDG-PET/CT Using Cascaded 2D and 3D Convolutional Neural NetworksSkander Jemaa, Jill Fredrickson, Richard A D Carano, et al.BMC Medical Imaging|February 18, 2025
Comparative analysis of intestinal tumor segmentation in PET CT scans using organ based and whole body deep learningMahsa Torkaman, Skander Jemaa, Jill Fredrickson, et al.The Oncologist|March 11, 2023
Meta-Analysis of 49 Roche Oncology Trials Comparing Blinded Independent Central Review (BICR) and Local Evaluation to Assess the Value of BICRQinshu Lian, Jill Fredrickson, Kamila Boudier, et al.Journal of Clinical Pharmacology|December 14, 2011
Quantitative model of the relationship between dipeptidyl peptidase-4 (DPP-4) inhibition and response: meta-analysis of alogliptin, saxagliptin, sitagliptin, and vildagliptin efficacy resultsJohn P Gibbs, Jill Fredrickson, Todd Barbee, et al.Hepatology (Baltimore, Md.)|August 22, 2022
Fibroblast growth factor receptor 1/Klothoβ agonist BFKB8488A improves lipids and liver health markers in patients with diabetes or NAFLD: A phase 1b randomized trialChin Wong, Ajit Dash, Jill Fredrickson, et al.BMC Medical Imaging|March 31, 2022
Heart and bladder detection and segmentation on FDG PET/CT by deep learningXiaoyong Wang, Skander Jemaa, Jill Fredrickson, et al.Magnetic Resonance in Medicine|February 27, 2016
Clinical translation of ferumoxytol-based vessel size imaging (VSI): Feasibility in a phase I oncology clinical trial populationJill Fredrickson, Natalie J Serkova, Shelby K Wyatt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2016
<sup>18</sup>F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent TrialsYingbing Wang, Karen L Ayres, Debra A Goldman, et al.Pageof 3